WO2010113183A3 - Process for the preparation of 1-[[[3-[2-(dimethylamino)ethyl]-1h-indol-5-yl]methyl]sulfonyl] pyrrolidine and its pharmaceutically acceptable salts - Google Patents
Process for the preparation of 1-[[[3-[2-(dimethylamino)ethyl]-1h-indol-5-yl]methyl]sulfonyl] pyrrolidine and its pharmaceutically acceptable salts Download PDFInfo
- Publication number
- WO2010113183A3 WO2010113183A3 PCT/IN2010/000216 IN2010000216W WO2010113183A3 WO 2010113183 A3 WO2010113183 A3 WO 2010113183A3 IN 2010000216 W IN2010000216 W IN 2010000216W WO 2010113183 A3 WO2010113183 A3 WO 2010113183A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- indol
- pyrrolidine
- sulfonyl
- dimethylamino
- ethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A process for preparation of 1-[[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]sulfonyl]pyrrolidine of Formula (1), which is commonly known as Almotriptan, and its pharmaceutically acceptable salts is provided. The required purity of almotriptan malate free of impurities is attained in three different ways, including by preparing the acid addition salts of amino indole compound, by proceeding through the almotriptan succinate and by specific purification of almotriptan malate from a suitable solvent.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN774CH2009 | 2009-04-03 | ||
IN774/CHE/2009 | 2009-04-03 | ||
IN546/CHE/2010 | 2010-03-03 | ||
IN546CH2010 | 2010-03-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010113183A2 WO2010113183A2 (en) | 2010-10-07 |
WO2010113183A3 true WO2010113183A3 (en) | 2010-12-29 |
Family
ID=42828790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2010/000216 WO2010113183A2 (en) | 2009-04-03 | 2010-04-01 | Process for the preparation of 1-[[[3-[2-(dimethylamino)ethyl]-1h-indol-5-yl]methyl]sulfonyl] pyrrolidine and its pharmaceutically acceptable salts |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010113183A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012085723A1 (en) * | 2010-12-20 | 2012-06-28 | Orchid Chemicals And Pharmaceuticals Limited | A process for the purification of almotriptan acid addition salt |
BR112013020362A2 (en) | 2011-02-10 | 2018-05-29 | Exelixis Inc | processes for the preparation of quinoline compounds, compounds and pharmaceutical combinations containing them |
CN102827062A (en) * | 2012-09-17 | 2012-12-19 | 扬子江药业集团四川海蓉药业有限公司 | Method for preparing almotriptan malate |
ES2505715T1 (en) | 2013-02-06 | 2014-10-10 | Galenicum Health S.L. | Pharmaceutical composition comprising almotriptan malate having a uniform distribution and potency |
CN103353494B (en) * | 2013-07-04 | 2014-12-31 | 山东省医药工业研究所 | HPLC (high performance liquid chromatography) detection method of related substances in almotriptan malate |
CN106397359B (en) * | 2016-08-31 | 2017-12-05 | 重庆华森制药股份有限公司 | The preparation method of almotriptan intermediate 4 (1 pyrrolidinyl sulfonymethyl) phenylhydrazine |
CN106478484B (en) * | 2016-08-31 | 2017-11-10 | 重庆华森制药股份有限公司 | A kind of method for preparing almotriptan key intermediate |
CN109928910B (en) * | 2017-12-19 | 2022-07-22 | 上海医药工业研究院 | Preparation method of anti-migraine drug almotriptan |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007013098A1 (en) * | 2005-07-25 | 2007-02-01 | Matrix Laboratories Limited | A process for the preparation of almotriptan |
WO2008151584A1 (en) * | 2007-06-13 | 2008-12-18 | Zentiva, A.S. | Method for the preparation of high purity almotriptan |
-
2010
- 2010-04-01 WO PCT/IN2010/000216 patent/WO2010113183A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007013098A1 (en) * | 2005-07-25 | 2007-02-01 | Matrix Laboratories Limited | A process for the preparation of almotriptan |
WO2008151584A1 (en) * | 2007-06-13 | 2008-12-18 | Zentiva, A.S. | Method for the preparation of high purity almotriptan |
Non-Patent Citations (1)
Title |
---|
KUMAR, A. PHANI ET AL.: "A Validated Reversed Phase HPLC Method for the Determination of Process-Related Impurities in Almotriptan Malate API.", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 46, 2008, pages 792 - 798 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010113183A2 (en) | 2010-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010113183A3 (en) | Process for the preparation of 1-[[[3-[2-(dimethylamino)ethyl]-1h-indol-5-yl]methyl]sulfonyl] pyrrolidine and its pharmaceutically acceptable salts | |
WO2007103456A3 (en) | Piperazine and piperidine biaryl derivatives | |
UA80834C2 (en) | Method of synthesising ivabradine and the salts thereof for addition to a pharmaceutically acceptable acid | |
NZ600207A (en) | Substituted 4-aminocyclohexane derivatives | |
WO2010076810A3 (en) | A process for the preparation of gefitinib | |
WO2020016749A3 (en) | Chemical process for preparing phenylpiperidinyl indole derivatives | |
WO2010062590A3 (en) | Process for the preparation of protected l-alanine derivatives | |
WO2011022596A3 (en) | Preparation of bazedoxifene and its salts | |
WO2009047499A3 (en) | Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes | |
WO2011128784A3 (en) | Novel process for preparing highly pure tapentadol or a pharmaceutically acceptable salt thereof | |
NZ600266A (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
WO2008045777A3 (en) | A process for the preparation of benzimidazole derivatives and their salts | |
WO2006114676A3 (en) | A process for the preparation of rupatadine | |
WO2008079266A3 (en) | Synthesis of pyrrolidine compounds | |
WO2008099286A3 (en) | Improved process for preparing ethyl (s)-2-ethoxy-4-[n-[1-(2- piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of repaglinide | |
MX2010009876A (en) | New process for the preparation of cyclohexanecarboxylic acid derivatives via the corresponding cyclohexanecarboxamide derivative. | |
WO2009075516A3 (en) | Process for preparing pantoprazole sodium sesquihydrate | |
WO2009021943A3 (en) | Novel preparation process | |
WO2008126106A8 (en) | Novel and improved processes for the preparation of intermediates of darifenacin, darifenacin and its pharmaceutically acceptable salts | |
WO2012004811A8 (en) | Process for the preparation of 5-substsituted indole derivative | |
WO2009084039A3 (en) | Process for producing 1-[2-(dimethylamino)-1-(4-phenol)ethyl]cyclohexanol | |
WO2008059513A3 (en) | Compounds suitable as modulators of hdl | |
NZ599147A (en) | Processes for the preparation of 2-(1-phenylethyl) isoindolin-1-one compounds | |
WO2008072257A3 (en) | Process for the preparation of indole derivatives | |
WO2010122580A3 (en) | Piperidine derivatives as inhibitors of renin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10758153 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10758153 Country of ref document: EP Kind code of ref document: A2 |